The novel coronavirus SARS-CoV-2 has spread across the world since 2019, causing a
global pandemic. The pathogenesis of the viral infection and the associated clinical …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the
Betacoronavirus genus (which also includes SARS 1 and Middle East respiratory syndrome …

Assessment of efficacy of therapeutic plasma exchange (TPE) following life-threatening
COVID-19. This was an open-label, randomised clinical trial of ICU patients with life …

Since its emersion, coronavirus disease 2019 (COVID‐19) has been a significant global
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …

Understanding and mitigating SARS-CoV-2 transmission hinges on antibody and viral RNA
data that inform exposure and shedding, but extensive variation in assays, study group …

The COVID‐19 pandemic caused relatively high mortality in patients, especially in those
with concomitant diseases (ie, diabetes, hypertension, and chronic obstructive pulmonary …

One of the striking features emerging from the COVID-19 pandemic has been the early
recognition of ethnic disparities in both vulnerability to contracting the disease, as well as its …

Abstract Coronavirus disease 2019 (COVID‐19), caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been a rising international cause of …

Rapid and inexpensive serological tests for SARS-CoV-2 antibodies are needed to conduct
population-level seroprevalence surveillance studies and can improve diagnostic reliability …